News

AlterNet on MSN9h
'Hunger games': Trump admin delivers another 'baffling' blow to US biosecurity
The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...
Healthbeat on MSN1d
In axing mRNA contracts, Trump delivers another blow to U.S. biosecurity, former officials say
The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...
In axing mRNA contract, Trump delivers another blow to US biosecurity, former officials say
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...
Valneva reports data from Phase II chikungunya vaccine trial in children
Valneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...
Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026
Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set ...
TMCnet2d
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
The strong immune response was confirmed in CHIKV-naïve children with a 96.5% seroresponse rate (full dose) at Day 180. VLA1553 was well tolerated in children aged one to eleven years regardless of ...
The Scientist2d
Preparing for Disease X in a Changing World
Any microbe, new or known, could cause an infection outbreak at any time. Researchers gear up to preemptively fight this ...
Panacea Biotec announces inclusion of EmulsiPan into prestigious CEPI Adjuvant Library
EmulsiPan is an oil-in-water emulsion adjuvant and is produced by nano-emulsification of squalene along with surfactants and buffers. Squalene is a naturally occurring biodegradable and biocompatible ...